Was not going public a missed opportunity for the large analytics company or the key to preserving its identity?

The biotech giant's new facility is part of a larger U.S. investment strategy, though it may roll back its buildout if the ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, ...